Community/Retail

The non-opioid drug can induce healing of joint cartilage in patients with osteoarthritis.

With the end of the PREP Act provisions approaching, we want to understand how pharmacists feel about their scopes of practice in each state, and what they think about the future of the profession.

Lebrikizumab (Ebglyss; Eli and Lilly Company) is a monthly maintenance injection with proven efficacy in adults and children aged 12 to 18 years.

For biosimilars to overcome these entrenched market dynamics, they must not only compete on price but actively work to build a network of support among providers and patients.

Pharmacists can help identify potential drug-drug interactions and adverse reactions, and advise patients when to seek further treatment

Not only do diverse clinical cohorts improve the strength of the data, but it improves public trust in clinicians and the medical system as a whole.

Exposure to high cholesterol levels is a significant risk factor for atherosclerosis cardiovascular disease.

The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.

The Hearing Aid Feature can be customized to the user’s needs by amplifying sounds for individuals 18 years or older who have perceived mild to moderate hearing impairments.

In the absence of a common treatment for long COVID, researchers from around the world documented the best currently available therapies.

Immediate-early 62 enclosed inside small extracellular vesicles can transport from the site of infection, causing it to penetrate cells and shut down their antiviral response.

As access becomes easier, pharmacists are more likely to encounter questions.

Investigators obtained real-world evidence to evaluate the clinical outcomes of non-medical switching from the infliximab (Remicade; Janssen Immunology) to a biosimilar.

Fred Barton discusses the role of PBMs in making prescription drug decisions.

Guselkumab (Tremfya; Johnson & Johnson) is the first and only approved fully human and dual-acting monoclonal antibody blocking interleukin-23 and binding to CD64 receptors.

Chronic fatigue is a related symptom with inflammatory bowel disease (IBD).

Programs can take several forms, including on-site clinics, voucher programs, and in-store events

Tune into this episode of “Public Health Matters” to learn about the Unbiased Science podcast and how guest Jessica Steier, DrPH, PMP, aims to combat misinformation and disinformation, encouraging listeners to make evidence-based decisions.

The investigators of the phase 3b trial (NCT04838444) will continue to follow up with patients for up to 10 years.

FCS is a severe, rare genetic disease in which patients have extremely high triglyceride levels, typically above 880 mg/dL.

The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment for pharmacies and their involvement in the cannabis market.

To help with treatment response and compliance as well as optimize treatment, communication between patients and health care providers is necessary.

The FDA assigned a Prescription Drug User Fee Action date is January 31, 2025.

Pharmacy students develop concept for exam augmented reality glasses for clinical situations and patient counsling.

Blaming community pharmacies and community pharmacists for a lack of expedited practice evolution is naive at best, and disingenuous or outright malicious at worst.